Live biotherapeutic products (LBPs), also termed as next-generation probiotics (NGPs), are rapidly developing because of their therapeutic potential. Clostridium organisms have promising potential in the development of cancer therapy. Learn more: clostridium novyi-nt as next generation probiotics